Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
242.43B | 239.29B | 223.28B | 202.44B | 225.31B | Gross Profit |
92.89B | 91.77B | 87.05B | 78.82B | 88.73B | EBIT |
4.20B | 8.33B | 5.00B | 2.77B | 5.25B | EBITDA |
9.72B | 12.39B | 9.25B | 7.22B | 9.68B | Net Income Common Stockholders |
2.59B | 5.40B | 3.84B | 412.00M | 408.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
24.94B | 32.89B | 39.89B | 44.32B | 12.49B | Total Assets |
209.53B | 211.30B | 208.31B | 207.48B | 182.92B | Total Debt |
10.96B | 12.63B | 15.18B | 15.43B | 4.74B | Net Debt |
-13.98B | -20.26B | -24.71B | -28.89B | -7.75B | Total Liabilities |
84.72B | 88.73B | 89.60B | 91.13B | 65.67B | Stockholders Equity |
124.45B | 122.36B | 118.66B | 116.31B | 117.21B |
Cash Flow | Free Cash Flow | |||
-2.86B | 1.38B | -2.78B | 20.13B | -6.51B | Operating Cash Flow |
4.27B | 7.02B | 2.23B | 25.37B | -1.30B | Investing Cash Flow |
-8.04B | -5.48B | -5.16B | -2.02B | -4.30B | Financing Cash Flow |
-4.14B | -7.91B | -2.12B | 8.51B | -418.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $567.69B | 21.22 | 10.45% | 1.10% | 17.94% | 18.31% | |
73 Outperform | $1.24T | 25.69 | 48.74% | 2.29% | 8.18% | 36.67% | |
71 Outperform | $5.77T | 33.40 | 4.37% | 1.93% | 4.37% | -21.49% | |
68 Neutral | ¥334.99B | 8.71 | 8.38% | 2.10% | 6.94% | 26.04% | |
67 Neutral | ¥56.46B | 17.01 | 2.54% | 3.10% | -3.05% | ||
64 Neutral | ¥675.19B | 9.77 | 11.80% | 2.47% | 5.77% | 64.67% | |
61 Neutral | $6.65B | 11.71 | 3.09% | 3.98% | 2.65% | -20.82% |
XEBIO Holdings Co., Ltd. has announced the acquisition of 189,500 of its common shares at a total cost of 230,605,354 yen through market purchases at the Tokyo Stock Exchange. This acquisition is part of a larger plan approved by the Board of Directors to buy back up to 3,000,000 shares, equivalent to 6.79% of the total shares issued, excluding treasury shares, by May 9, 2025. The move is aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
XEBIO Holdings CO., LTD. has announced a business structural reform to adapt to changing market conditions and improve financial performance, aiming for a 6% ROE by March 2027. This includes recognizing extraordinary losses, revising earnings forecasts, and increasing dividends. The company plans to focus on core businesses by restructuring and standardizing formats, optimizing procurement, and closing unprofitable stores. It will also integrate peripheral businesses, enhance governance, and invest in human resources to improve profitability and shareholder returns.
XEBIO Holdings Co., Ltd. announced changes in its board of directors and audit and supervisory board members, effective June 27, 2025. The changes include the reappointment of several directors and the appointment of Shoichi Mukaiyachi as a new outside audit and supervisory board member, replacing the retiring Hitoshi Kanno.
XEBIO Holdings CO., LTD. has announced the acquisition of 194,600 treasury shares at a total cost of 239,179,912 yen, as part of a resolution made by its Board of Directors. This acquisition is part of a larger plan to buy back up to 3,000,000 shares, equivalent to 6.79% of the total shares issued, to enhance shareholder value and optimize capital structure.